Evotec and Odyssey collaborate on AI-enabled R&D
The partnership intends to leverage complementary scientific strengths to boost early-stage research and produce new medicines.
Drug Development
Mediar and Ono Pharmaceutical to develop fibro-inflammatory treatments
Alteogen signs $365m Hybrozyme licensing deal with pharma company
Schrödinger and BMS expand partnership to deploy AI for drug discovery
AsymBio to secure $184m to support growth in biologics manufacturing
Phylo and Chugai collaborate to deploy AI platform in drug discovery
FDA grants breakthrough therapy designation to Lilly’s olomorasib
Curium to acquire Lantheus in all-cash deal worth up to $8bn
